Clarity Pharmaceuticals’ copper theranostics platform delivers superior prostate cancer imaging results
October 21, 2025 Latest News
New Stories
-
IDT Australia sharpens strategy with cost savings and radiopharmaceutical focus
October 21, 2025 - - Latest News -
Clarity Pharmaceuticals’ copper theranostics platform delivers superior prostate cancer imaging results
October 21, 2025 - - Latest News -
PYC Therapeutics launches global repeat-dose trial for potential first-in-class ADOA treatment
October 21, 2025 - - Latest News -
Neuren secures FDA 'Fast Track Designation' for NNZ-2591 in Phelan-McDermid Syndrome
October 20, 2025 - - Latest News -
Radiopharm secures funding to accelerate radiopharmaceutical pipeline as data show strong momentum
October 20, 2025 - - Latest News -
Monash scientists crack genetic ‘code’ behind RNA splicing, opening door to to new therapies
October 20, 2025 - - Latest News -
Algorae partners with Cadila Pharmaceuticals to launch therapies in Australia and New Zealand
October 20, 2025 - - Latest News